What does an unfused proximal hand epiphysis and unfused facial growth centers at age 16 years 8 months with normal bone age on X‑ray indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Unfused Proximal Hand and Facial Growth Centers at Age 16 Years 8 Months with Normal Bone Age

Unfused proximal hand epiphyses and facial growth centers at age 16 years 8 months with normal bone age indicates ongoing skeletal maturation that is appropriate for chronological age, suggesting continued growth potential and the need to evaluate for possible growth hormone excess or syndromic conditions.

Clinical Interpretation

The presence of unfused epiphyses at this age requires careful contextualization:

Normal Developmental Timeline

  • Proximal hand epiphyses typically complete fusion between ages 17-19 years in males and 16-18 years in females 1
  • At 16 years 8 months, unfused proximal hand epiphyses fall within the expected developmental window, particularly for males
  • Normal bone age matching chronological age indicates appropriate skeletal maturation velocity without acceleration or delay

Facial Growth Considerations

Facial growth centers typically remain active until radius-ulna fusion is complete 2. Research demonstrates that:

  • After radius-ulna fusion (R-J stage), vertical dentoalveolar growth changes of 0.5-1.75 mm still occur in 20% of subjects in the mandible and 10% in the maxilla 2
  • Most facial growth ceases by the time proximal radial epiphysis completes fusion
  • At age 16 years 8 months with unfused proximal hand epiphyses, continued facial growth is expected and normal

Critical Differential Considerations

When to Suspect Pathology

Evaluate for growth hormone excess (acromegalic gigantism) if:

  • Linear growth acceleration with increased height velocity
  • Macrocephaly or coarse facial features developing
  • Bone age is normal or advanced (not delayed) 3
  • IGF-1 levels >+2 SDS for age, sex, and pubertal stage 3

This is particularly important because bone age can be normal or advanced in growth hormone excess 3, making it a poor discriminator. The combination of normal bone age with unfused epiphyses at this age does not exclude pathology.

Syndromic Overgrowth Conditions

Consider genetic evaluation if accompanied by:

  • Disproportionate overgrowth or macrosomia
  • Characteristic dysmorphic features
  • Family history of pituitary adenomas or endocrine neoplasia syndromes (MEN1, MEN4, FIPA, X-LAG) 3

Genetic panel analysis should be proposed systematically if acromegaly is diagnosed during adolescence 3.

Clinical Action Algorithm

  1. Document growth parameters:

    • Height, weight plotted on growth curves
    • Height velocity over past 6-12 months
    • Pubertal staging (Tanner stage)

  2. Screen for growth hormone excess if:

    • Height velocity elevated for age
    • Clinical features of acromegaly present
    • Measure IGF-1 (standardized for sex, age, pubertal stage) 3
    • If IGF-1 elevated: perform oral glucose tolerance test (OGTT) with GH measurement 3

  3. Reassurance if:

    • Growth velocity appropriate for age and pubertal stage
    • No dysmorphic features
    • IGF-1 within normal range
    • Patient is male (later fusion expected)

  4. Follow-up imaging:

    • Repeat hand-wrist radiograph in 6-12 months to document progression toward fusion
    • Expected complete fusion by age 18-19 years in males, 17-18 years in females 1

Common Pitfalls to Avoid

  • Do not assume normal bone age excludes pathology - growth hormone excess presents with normal or advanced bone age, not delayed 3
  • Do not dismiss unfused epiphyses as abnormal at this age without considering sex-specific fusion timelines 1
  • Do not order routine imaging for age estimation alone without clinical indication, as this exposes patients to unnecessary radiation 4
  • Do not overlook syndromic features - carefully examine for subtle dysmorphisms that might indicate genetic overgrowth syndromes 5

Sex-Specific Considerations

Males: Unfused proximal hand epiphyses at 16 years 8 months are within normal limits, with expected fusion completion by 18-19 years 1.

Females: This finding warrants closer attention, as females typically complete fusion by 17-18 years 1. If the patient is female, more aggressive evaluation for growth disorders is indicated.

References

1
Research

Age of fusion of the distal radial and ulnar epiphyses from hand radiographs-A study in Kashmiri population.

Science & justice : journal of the Forensic Science Society, 2016

Related Questions

What does it mean that the radial growth plate (physis) is nearly fused?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
Should a pregnancy test be performed before administering the live‑attenuated varicella (chickenpox) vaccine to a woman of child‑bearing potential?
Given a copeptin level of 4.6 pmol/L (normal for non‑fasting adults), serum sodium 143 mmol/L, and urine osmolality 498 mOsm/kg after a 12‑hour fluid restriction, does this rule out diabetes insipidus, and what further evaluation or management is needed if the patient has persistent polyuria or polydipsia?
Can glycopyrrolate (Robinul) be combined with scopolamine to control excessive secretions?
In a patient with blunt chest trauma who now shows ST‑segment elevation on the electrocardiogram and elevated troponin, could this represent a cardiac contusion and how should it be managed?
What is the appropriate workup and initial management for a 38-year-old man with a two‑week history of dyspnea on exertion, hemoglobin 17.1 g/dL, platelet count 737 ×10⁹/L, and triglycerides 368 mg/dL?
Is dystonia scored on the Abnormal Involuntary Movement Scale (AIMS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.